Stock Taper 
TRI LOCUM PARTNERS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 argenx SE | ARGX | 41.6K | $38.59M |
 United Therapeutics Corporation | UTHR | 47.03K | $25.48M |
 Intuitive Surgical, Inc. | ISRG | 47.98K | $19.08M |
 Madrigal Pharmaceuticals, Inc. | MDGL | 68.27K | $36.66M |
 Eli Lilly and Company | LLY | 76.53K | $91.79M |
 Dianthus Therapeutics, Inc. | DNTH | 120.71K | $11.77M |
 Revolution Medicines, Inc. | RVMD | 151.82K | $28.43M |
 Definium Therapeutics, Inc. | DFTX | 163K | $7.67M |
 Cytokinetics, Incorporated | CYTK | 194K | $16.53M |
 Vertex Pharmaceuticals Incorporated | VRTX | 201.79K | $100.24M |
 Axsome Therapeutics, Inc. | AXSM | 219.31K | $53.68M |
 Jazz Pharmaceuticals plc | JAZZ | 221.72K | $53.43M |
 Ascendis Pharma A/S | ASND | 258.74K | $69.01M |
 Tarsus Pharmaceuticals, Inc. | TARS | 328.34K | $20.67M |
 Johnson & Johnson | JNJ | 424.94K | $107.92M |
 Beta Bionics, Inc. | BBNX | 493.34K | $7.73M |
 Teva Pharmaceutical Industries Limited | TEVA | 746.84K | $25.3M |
 DexCom, Inc. | DXCM | 820.48K | $55.26M |
 Enliven Therapeutics, Inc. | ELVN | 866.72K | $43.99M |